The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
HYOSCINE BUTYLBROMIDE (AFT Pharmaceuticals Pty Ltd)
Product name
HYOSCINE BUTYLBROMIDE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
135 (255 working days)
Active ingredients
Hyoscine butylbromide
Registration type
New generic medicine
Indication
Spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.